Truist Financial Cuts Evolent Health (NYSE:EVH) Price Target to $14.00
Evolent Health (NYSE:EVH – Get Free Report) had its target price decreased by research analysts at Truist Financial from $15.00 to $14.00 in a report issued on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the technology company’s stock. Truist Financial’s target price would indicate a potential upside of 39.71% from the company’s […]
